2017年2月26日 星期日

[懶懶熊兄妹] 蒜炒香菇金針菇鹹鴨蛋黃飯糰




今天自己揉蒜炒香菇金針菇鹹鴨蛋黃飯糰,然後用之前去日本買的小豆豆妹飯糰紙包成一團,然後緯緯就吃了三顆,自己吃都不用人家催,

叡叡今天出去吃飯,吃的很開心,視訊看到爸爸媽媽就開始嘰哩呱啦,看到哥哥玩玩具也會拿起自己玩具車起來!

2017年2月25日 星期六

[新聞] 中醫師公會全國聯合會認為國防部試圖以中藥做為掩蓋國軍毒品醜聞案的卸責之詞,因與事實真相不符,且在缺乏完整論述與臨床實證下,恐引發民眾對於中藥材之恐慌與誤解

中華民國中醫師公會全國聯合會

中醫師公會全國聯合會認為國防部試圖以中藥做為掩蓋國軍毒品醜聞案的卸責之詞,因與事實真相不符,且在缺乏完整論述與臨床實證下,恐引發民眾對於中藥材之恐慌與誤解,發布3點聲明:
一、無論任何中、西藥,都須針對個別病人之體質及病況,經中、西醫師診斷開立處方箋後,始得服用,合先敘明。
二、任何司法偵審機關將毒品案之被告尿液等檢體送複驗後,其複驗報告所呈現之數據資料,絕無可能出現與中藥材有關之名稱與數據,當前更無任何醫學文獻指出,服用中藥與毒品檢驗呈陽性反應有關聯性。
三、國防部對於國軍毒品醜聞案,不思檢討軍紀與革新犯罪預防措施,率爾卸責予中醫藥,有失實事求是之科學精神,亦難獲得國人諒解與認同,本會表達嚴正抗議之餘,更請行政院與監察院主動介入查察,釐清真相,避免爾後再生此類事件,以維護我國醫療形象。

2017年2月24日 星期五

[教學] 北榮傳醫部張清貿醫師核心課程教學:BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine



時間:2017/02/23 週四上午9點半
課程:Paper Reading
教學醫師:張清貿醫師
範圍:BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine
地點:傳醫部會議室

2017年2月14日 星期二

[演講] 2016年03月12日,2017年第87屆國醫節第9屆臺北國際中醫藥學術論壇 Systemic Lupus Erythematosus 紅斑性狼瘡演講 張清貿醫師 - 整合中西醫療法可降低紅斑性狼瘡患者併發狼瘡腎炎之風險


2017年第87屆國醫節
第9屆臺北國際中醫藥學術論壇
Systemic Lupus Erythematosus 紅斑性狼瘡演講

整合中西醫療法可降低紅斑性狼瘡患者併發狼瘡腎炎之風險


大會時間:2017年3月12日(星期日) 下午14:50-15:10
大會地點:台北市徐州路2號/台大醫院國際會議中心
演講主題:整合中西醫療法可降低紅斑性狼瘡患者併發狼瘡腎炎之風險
演講者:張清貿醫師
                臺北榮民總醫院傳統醫學部主治醫師
                長庚大學臨床醫學研究所博士候選人

2017年2月13日 星期一

[論文發表] Integrative therapy decreases the risk of lupus nephritis in patients with systemic lupus erythematosus: A population-based retrospective cohort study,整合中西醫療法可降低紅斑性狼瘡患者併發狼瘡腎炎之風險



 2017 Jan 20;196:201-212. doi: 10.1016/j.jep.2016.12.016. Epub 2016 Dec 12.

Integrative therapy decreases the risk of lupus nephritis in patients with systemic lupus erythematosus: A population-based retrospective cohort study.


整合中西醫療法可降低紅斑性狼瘡患者併發狼瘡腎炎之風險



Abstract

ETHNOPHARMACOLOGICAL RELEVANCE:

Evidence on alleviating the risk of lupus nephritis by integrative therapy with conventional medicine (CM) and herbal medicine (HM) had not been addressed.

AIM OF THE STUDY:

We investigated the integrative effect associated the risk by a retrospective Systemic Lupus Erythematosus (SLE) cohort from Taiwan National Health Insurance Research Database (NHIRD).

MATERIALS AND METHODS:

SLE patients with a catastrophic illness certificate (CIC) were retrospectively enrolled from the SLE cohort of the Taiwan NHIRD between 1997 and 2011. The patients were divided into an integrative medicine (IM: integrated CM plus HM) and a non-IM (CM only) group with 1:1 propensity score matching. Cox proportional regression model and the Kaplan-Meier method were conducted to estimate the hazard ratio (HR) for lupus nephritis in the cohort.

RESULTS:

Among 16,645 newly diagnosed SLE patients holding a CIC (SLE/CIC), 1933 had received HM and 1571 had received no HM treatment. After propensity score matching, there were 273 patients with lupus nephritis-120 in the IM group and 153 in the non-IM group. The adjusted HR (0.68, 95% confidence interval [CI]: 0.54-0.87, p<0.01) for lupus nephritis was lower in the IM group than in the non-IM group. The adjusted HR (0.69, 95% CI: 0.54-0.88, p<0.001) for lupus nephritis was also lower in the group of patients who had received CM plus HM than in the group that received CM only. The core pattern of HM prescriptions, which were integrated with CM for preventing lupusnephritis, was "Sheng-Di-Huang" (raw Rehmannia glutinosa Libosch.), "Mu-Dan-Pi" (Paeonia suffruticosa Andr.), "Dan-Shan" (Salvia miltiorrhiza Bge.), "Zhi-Bo-Di-Huang-Wan.", and "Chi-Shao" (Paeoniae lactiflorae Rubra).

CONCLUSION:

Integrative therapy decreased the risk of lupus nephritis among SLE patients in Taiwan. Further investigation of the pharmacological mechanism and clinical efficacy are warranted.

KEYWORDS:

Complementary and alternative medicine; Herbal medicine; Integrative therapyLupus nephritisSystemic lupus erythematosus




2017年2月9日 星期四

[論文發表] Clinical efficacy of Rong-Yang-Jyh-Gan-Tang on patients with chronic hepatitis C: A double-blinded randomized placebo-controlled crossover study,榮陽治肝湯治療慢性C型肝炎之臨床療效



 2017 Jan 20;196:1-8. doi: 10.1016/j.jep.2016.12.013. Epub 2016 Dec 10.

Clinical efficacy of Rong-Yang-Jyh-Gan-Tang on patients with chronic hepatitis C: A double-blinded randomized placebo-controlled crossover study.


榮陽治肝湯治療慢性C型肝炎之臨床療效



Abstract

ETHNOPHARMACOLOGICAL RELEVANCE:

Traditional Chinese medicine (TCM) has been widely used by the Chinese population for treatment of chronic hepatitis. However, the efficacy of TCM for patients with chronic hepatitis has not been confirmed, mostly due to the lack of available scientific parameters such as serum viral load to evaluate treatment response.

AIM OF THE STUDY:

We evaluated the efficacy of Rong-Yang-Jyh-Gan-Tang (RYJGT, composed of Long-Dan-Xie-Gan-Tang, Jia-Wei-Xia-Yao-San, Dan-Shen, and Hou-Po) on patients with chronic hepatitis C.

MATERIALS AND METHODS:

Thirty-six patients with chronic hepatitis C who had no response to or had contraindications to interferon-ribavirin therapy were randomly allocated to receive RYJGT 15g/day or placebo for 12 weeks. After a 2-week washout period, patients were crossed over to receive placebo or RYJGT for another 12 weeks. Evaluation parameters included liver biochemistries, serum HCVRNA, side effects of RYJGT/placebo, and TCM symptoms.

RESULTS:

Of the patients who had 12-week RYJGT treatment, 51.7% had decreased serum HCVRNA levels, whereas only 25.8% patients had decreased levels in the placebo group (p=0.036). TCM patterns of "Damp-Heat" and "Liver Qi Depression" had significantly improved after RYJGT treatment in comparison with the placebo. Logistic analyses showed that RYJGT treatment, and pre-treatment values of TCM symptoms of "Damp-Heat" and "Liver Qi Depression", were statistically significant factors in predicting the decrease in serum HCVRNA.

CONCLUSION:

Chronic hepatitis C patients who received a 12-week RYJGT treatment had significantly higher HCVRNA decrease ratio, and improved TCM symptoms of "Damp-Heat" and "Liver Qi Depression", than those who received the placebo. Our results require further larger scale clinical trials.

KEYWORDS:

Chronic hepatitis C; Fatigue severity score; Hepatitis C viral RNA; Quality of life; Rong-Yang-Jyh-Gan-Tang; Serum liver transaminase